<?xml version="1.0" encoding="utf-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd"><url><loc>https://www.mlo-online.com/continuing-education/news/55407527/free-ce-webinar-full-process-quality-control-in-clinical-flow-cytometry</loc><news:news><news:publication><news:name>MLO Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-24T15:03:56.000Z</news:publication_date><news:title>Free CE webinar: Full-process quality control in clinical flow cytometry</news:title></news:news></url><url><loc>https://www.mlo-online.com/diagnostics/news/55407523/grails-galleri-mced-receives-favorable-vote-from-fda-committee</loc><news:news><news:publication><news:name>MLO Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-24T14:58:38.000Z</news:publication_date><news:title>GRAIL's Galleri MCED receives favorable vote from FDA Committee </news:title></news:news></url><url><loc>https://www.mlo-online.com/disease/cancer/news/55407179/study-shows-promise-of-multicancer-early-detection-tests</loc><news:news><news:publication><news:name>MLO Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-23T15:17:01.000Z</news:publication_date><news:title>Study shows promise of multicancer early detection tests </news:title></news:news></url><url><loc>https://www.mlo-online.com/diagnostics/news/55407176/werfen-receives-fda-clearance-and-ce-mark-for-aptiva-antiphospholipid-syndrome-iga-reagent-expanding-aps-testing-access</loc><news:news><news:publication><news:name>MLO Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-23T15:09:44.000Z</news:publication_date><news:title>Werfen receives FDA clearance and CE Mark for Aptiva Antiphospholipid Syndrome IgA Reagent, expanding APS testing access </news:title></news:news></url></urlset>